Masthead (Adv. Therap. 2/2020).
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.202070004
- Publication type:
- Article
Works matching IS 23663987 AND DT 2020 AND VI 3 AND IP 2
Results: 15
1
2
Antisense Oligonucleotides: A 50‐nm‐Sized Micellar Assembly of Thermoresponsive Polymer‐Antisense Oligonucleotide Conjugates for Enhanced Gene Knockdown in Lung Cancer by Intratracheal Administration (Adv. Therap. 2/2020).
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.202070003
- By:
- Publication type:
- Article
3
Improvement of Cell Penetrating Peptide for Efficient siRNA Targeting of Tumor Xenografts in Zebrafish Embryos.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900204
- By:
- Publication type:
- Article
4
Oral Delivery of Multicompartment Nanomedicines for Colorectal Cancer Therapeutics: Combining Loco‐Regional Delivery with Cell‐Target Specificity.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900171
- By:
- Publication type:
- Article
5
A Versatile Polymer‐Based Platform for Intracellular Delivery of Macromolecules.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900169
- By:
- Publication type:
- Article
6
Macrophage‐Mediated Delivery of Hypoxia‐Activated Prodrug Nanoparticles.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900162
- By:
- Publication type:
- Article
7
Coating‐Sheddable CD44‐Targeted Poly(d,l‐lactide‐co‐glycolide) Nanomedicines Fabricated by Using Photoclick‐Crosslinkable Surfactant.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900160
- By:
- Publication type:
- Article
8
Nanocomposite Polymer Scaffolds Responding under External Stimuli for Drug Delivery and Tissue Engineering Applications.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900143
- By:
- Publication type:
- Article
9
Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900136
- By:
- Publication type:
- Article
10
A 50‐nm‐Sized Micellar Assembly of Thermoresponsive Polymer‐Antisense Oligonucleotide Conjugates for Enhanced Gene Knockdown in Lung Cancer by Intratracheal Administration.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900123
- By:
- Publication type:
- Article
11
Lysyl Oxidase Like‐2 (LOXL2): An Emerging Oncology Target.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900119
- By:
- Publication type:
- Article
12
Recent Advances in the Transdermal Delivery of Protein Therapeutics with a Combinatorial System of Chemical Adjuvants and Physical Penetration Enhancements.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900116
- By:
- Publication type:
- Article
13
Recent Advances in the Design of Self‐Delivery Amphiphilic Drugs and Vaccines.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900107
- By:
- Publication type:
- Article
14
Precision Medicine in Oncology: In Vitro Drug Sensitivity and Resistance Test (DSRT) for Selection of Personalized Anticancer Therapy.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900100
- By:
- Publication type:
- Article
15
Engineering the Tenogenic Niche In Vitro with Microenvironmental Tools.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 2, p. 1, doi. 10.1002/adtp.201900072
- By:
- Publication type:
- Article